Loma Linda University
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Loma Linda University sits in the top decile of US sponsors by registered trial count (#138 of 15,742 sponsors by registered trial count).
Loma Linda University: 237 sponsored US clinical trials, 35 recruiting.
Loma Linda University sponsors 237 registered US clinical trials on ClinicalTrials.gov, 35 of them currently recruiting, and 154 completed. 22 of these trials are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Inflammation, with 4 trials.
Top-decile sponsor footprint
Loma Linda University ranks in the top decile of sponsors by registered trial count (#138 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
154 of 186 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
237 total, page 4 of 5
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
NCT02672098
Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures
NCT02805504
Port Site Pain Following Percutaneous Externally-Assembled Laparoscopic Donor Nephrectomy
NCT02805517
Percutaneous Externally-Assembled Laparoscopic Urologic Surgery
NCT02811601
Subchondral Perfusion Mapping Using Indocyanin Green Laser
NCT02918383
Food Response Training for Binge Eating
NCT02817412
External Nasal Dilator and Oxygen Therapy in Respiratory Failure
NCT02662387
Adjuvant Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Gastric Cancer
NCT02672865
Epiretinal Membrane and Pseudophakic Cystoid Macular Edema
NCT02693353
Reversible Pulmonary Artery Banding as Simplified Management of End-stage Dilated Left Ventriculopathy in Early Life
NCT02652676
Effects of Soy Based Dietary Supplements on Cardiometabolic Risk Factors.
NCT02490683
Measuring Blood Flow Characteristics Using Dynamic Contrast Enhanced Magnetic Resonance Imaging
NCT02702635
Implications of Tamarkoz® on Stress, Emotion, Spirituality and Heart Rate
NCT03489148
Oral Steroids in Chronic Rhinosinusitis Without Nasal Polyps
NCT02927834
Liposomal Bupivacaine in Implant Based Breast Reconstruction
NCT02659501
Cognitive Impact of Pomegranate Polyphenols Following Ischemic Stroke
NCT02442804
"The Effect of Humor and Laughter on C Reactive Protein: A Pilot Study"
NCT02415231
Pain and Stress Assessment and ROP Screening
NCT02415205
Remote Ischemic Pre-conditioning in Subarachnoid Hemorrhage
NCT02381522
Egg Intake and Risk of Type 2 Diabetes
NCT03406910
IVES for Treatment of UUI and OAB
NCT02992509
Bacterial Resistance in Patients Receiving Post-Intravitreal Injection Antibiotics
NCT02223338
The Role of B Cells in Kidney Allograft Dysfunction
NCT02294032
Non-pharmacological Interventions for Procedural Pain in Premature Neonates
NCT02214589
A Comparison of Midazolam and Zolpidem as Oral Premedication in Children
NCT02096900
"The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"
NCT02180048
PK/PD of High Dose Pip/Tazo in Obese Patients
NCT01923363
Evaluation of Needle Core Biopsy of Axillary Sentinel Lymph Node in Breast Cancer
NCT02046057
Effects of Music Listening on Pain and Patient Satisfaction Within First 48 Hours After Knee Replacment Surgery
NCT02039271
Oral Sucrose Versus Glucose for Procedural Pain in Premature Neonates
NCT01894659
A Comparison of Bone Formation With Three Different Bone Graft Materials Following Sinus Graft
NCT01911819
Walnuts and Glucose Variability
NCT01787214
The Impact of Emergency Physician Empathy on Litigation Propensity
NCT01837706
A Phase II Trial of Preoperative Proton Therapy in Soft-tissue Sarcomas of the Extremities and Body Wall
NCT01819831
Study of the Efficacy of Topical Nasal Steroids Patients With Nasal Polyps
NCT01777906
Comparison of Adenoma Detection Rate Among Water, Carbon Dioxide and Air Methods of Minimal Sedation Colonoscopy
NCT01782014
Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer
NCT01683422
Comparison of Clinical Outcomes and Performance of Total Knee Replacement Patients Before and After Surgery
NCT01379118
Analgesia in Children Using Caudal Epidural Ropivacaine
NCT01494272
Observational Study of Citrate Based Dialysis in Pediatric Patients Receiving Hemodialysis
NCT01590550
Walnuts and Healthy Aging
NCT01634841
The Effect of Bone Grafts on Facial Gingival Profile in Maxillary Anterior Single Tooth Replacement
NCT01547273
Efficacy of Oral Versus Intravenous Acetaminophen for Primary Pediatric Cleft Palate Repair
NCT01500109
Comparison of 2 Laryngoscopes for Endotracheal Intubation in Children Younger Than 2 Years Old
NCT01488370
Methemoglobin Levels in Generally Anesthetized Pediatric Dental Patients Receiving Local Anesthetics
NCT01402869
Effects of CoSeal on Bleeding & Adhesions in Pediatric Heart Surgery
NCT01330433
Hand Injected Ventriculography vs. Power Injected Left Ventriculography
NCT01310517
Comparison of Skin Incision Closure Material for the Transobturator Suburethral Sling Procedure
NCT01313754
The Effect of Sonophoresis on Topical Anesthesia: A Pilot Study
NCT01283490
Incorporating Avocados in Meals
NCT01271829
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 7 |
| Phase 3 | 12 |
| Phase 4 | 10 |
Therapeutic Areas
Where Loma Linda University enrollment is open (later-stage tilt)
35 recruiting of 237 indexed (15% open); 154 completed (65%).
Phase mix: 22 late (III/IV) vs 14 early (I/II) (later-stage heavy).
Top condition: Inflammation (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Loma Linda University: open-pipeline peers nationwide
Peers matched on 237 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Loma Linda University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 237 trials (± recruiting share)
- Daiichi Sankyo · 236 trials · 12% recruiting
- Incyte Corporation · 239 trials · 15% recruiting
- University of Massachusetts, Worcester · 240 trials · 13% recruiting
- Henry Ford Health System · 234 trials · 18% recruiting
Sponsors near 15% open enrollment (± trial volume)
- University of Rochester · 15% recruiting · 636 trials
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Brown University · 15% recruiting · 231 trials
Related
What to do with this Loma Linda University page
237 registered trials is a research-attention snapshot, not an endorsement of Loma Linda University or any single study.
- 35 of Loma Linda University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Inflammation is the condition Loma Linda University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Inflammation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Loma Linda University pipeline card: 237 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.